A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05372354 · RECRUITING
Trial details
- NCT number
- NCT05372354
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2026-10-12
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.